Pfizer's CEO Highlights Consistent Growth at Goldman Sachs Healthcare Conference
Pfizer Inc. (PFE) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Seeking Alpha
Image: Seeking Alpha
At the Goldman Sachs 47th Annual Global Healthcare Conference in Miami, Pfizer's CEO Albert Bourla emphasized the company's consistent revenue and earnings growth since adapting its commercial model post-COVID, aided by AI and cost reduction strategies.
- 01Pfizer has consistently exceeded revenue and earnings per share (EPS) expectations for 2024, 2025, and Q1 2026.
- 02The company implemented significant changes to its commercial model after the COVID-19 pandemic.
- 03AI technology played a crucial role in Pfizer's ability to reduce costs while maintaining performance.
- 04Albert Bourla has been a regular speaker at this annual conference, highlighting the company's strategic direction.
- 05The conference took place on June 8, 2026, in Miami, Florida.
Advertisement
In-Article Ad
During the Goldman Sachs 47th Annual Global Healthcare Conference held on June 8, 2026, in Miami, Pfizer Inc.'s CEO Albert Bourla discussed the company's strong performance and strategic direction. Bourla noted that Pfizer has consistently surpassed revenue and earnings per share (EPS) expectations in 2024, 2025, and the first quarter of 2026. This success is attributed to significant changes made to the company's commercial model in the aftermath of the COVID-19 pandemic. He emphasized the importance of 'consistency in delivery' and highlighted the role of artificial intelligence (AI) in facilitating cost reductions while enhancing operational effectiveness. Bourla expressed satisfaction with the ongoing execution of their strategy, which has allowed Pfizer to adapt and thrive in a changing healthcare landscape. The conference, which Bourla has traditionally opened, serves as a platform for discussing key developments in the healthcare sector and Pfizer's position within it.
Advertisement
In-Article Ad
Advertisement
In-Article Ad
Reader Poll
What do you think about Pfizer's growth strategy?
Connecting to poll...
Read the original article
Visit the source for the complete story.




